We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
-4.76%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$146M
AUM Growth
+$1.59M
(+1.1%)
Cap. Flow
-$24.6M
Cap. Flow
% of AUM
-16.85%
Top 10 Holdings %
Top 10 Hldgs %
38.04%
Holding
721
New
108
Increased
208
Reduced
56
Closed
337
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$3.14M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.9M |
| 3 |
Morgan Stanley
MS
|
+$850K |
| 4 |
Amgen
AMGN
|
+$602K |
| 5 |
MRSH
Marsh
MRSH
|
+$592K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.3M |
| 2 |
AIMT
Aimmune Therapeutics
AIMT
|
+$16.5M |
| 3 |
Merck
MRK
|
+$1.15M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$807K |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$596K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.21% |
| 2 | Financials | 10% |
| 3 | Technology | 8.09% |
| 4 | Industrials | 7.22% |
| 5 | Real Estate | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIMT
1
DELISTED
Aimmune Therapeutics
AIMT
| $18.5M | 12.66% |
580,000
-470,000
| -45% | -$16.5M |
|
|
2
State Street Health Care Select Sector SPDR ETF
XLV
$41.5B
| $8.7M | 5.97% |
106,933
+22,354
| +26% | +$1.9M |
|
|
3
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $8.42M | 5.77% |
31,993
-70,832
| -69% | -$19.3M |
|
|
4
iShares Russell 2000 ETF
IWM
$81.1B
| $4.55M | 3.12% |
30,003
-5,223
| -15% | -$807K |
|
5
Pfizer
PFE
$142B
| $3.76M | 2.58% |
111,596
+1,156
| +1% | +$39.7K |
|
|
6
iShares Biotechnology ETF
IBB
$9.31B
| $3.54M | 2.42% |
33,128
+28,328
| +590% | +$3.14M |
|
|
7
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.5B
| $2.45M | 1.68% |
1,187,700
+430,000
| +57% | +$36.6M |
|
|
8
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $2.03M | 1.39% |
288,100
-503,100
| -64% | -$137M |
|
|
9
Amgen
AMGN
$197B
| $1.94M | 1.33% |
11,364
+3,280
| +41% | +$602K |
|
10
PUT
iShares S&P 100 ETF
OEF
$19.8B
| $1.62M | 1.11% |
595,300
+422,000
| +244% | +$51.1M |
|
11
Eli Lilly
LLY
$1.05T
| $1.4M | 0.96% |
18,131
+6,624
| +58% | +$533K |
|
|
12
Morgan Stanley
MS
$339B
| $1.39M | 0.95% |
25,791
+15,360
| +147% | +$850K |
|
|
13
Merck
MRK
$321B
| $1.16M | 0.79% |
22,230
-21,210
| -49% | -$1.15M |
|
|
14
State Street Financial Select Sector SPDR ETF
XLF
$54.9B
| $983K | 0.67% |
35,661
-20,679
| -37% | -$596K |
|
15
Goldman Sachs
GS
$317B
| $801K | 0.55% |
3,180
+1,693
| +114% | +$441K |
|
16
Equity Residential
EQR
$25.7B
| $790K | 0.54% |
12,819
+1,947
| +18% | +$116K |
|
|
17
PUT
Pfizer
PFE
$142B
| $749K | 0.51% |
856,691
+158,100
| +23% | +$5.44M |
|
18
Simon Property Group
SPG
$73.7B
| $744K | 0.51% |
4,820
+2,548
| +112% | +$405K |
|
19
Caterpillar
CAT
$416B
| $639K | 0.44% |
4,338
+2,143
| +98% | +$338K |
|
|
20
PUT
Amgen
AMGN
$197B
| $625K | 0.43% |
57,100
+23,600
| +70% | +$4.33M |
|
21
Hartford Financial Services
HIG
$38.8B
| $604K | 0.41% |
11,731
+823
| +8% | +$45K |
|
22
Allstate
ALL
$65B
| $598K | 0.41% |
6,309
+883
| +16% | +$85.5K |
|
|
MRSH
23
Marsh
MRSH
$83.7B
| $590K | 0.4% |
+7,143
| New | +$592K |
|
24
Ovintiv
OVV
$17.5B
| $589K | 0.4% |
10,718
+4,509
| +73% | +$268K |
|
25
Citigroup
C
$221B
| $586K | 0.4% |
8,679
+4,959
| +133% | +$373K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q1 2018 Portfolio in Review
As of Q1 2018, TLP Group held 721 positions worth $146M, up 1.1% from $144M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
TLP Group withdrew a net $24.6M in Q1 2018, closing 337 positions and reducing 56 holdings. Its most notable exit was Under Armour, an estimated $487K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 8.7% a quarter earlier, followed by Financials and Technology.
Against the trend, TLP Group opened a new position in Marsh worth $590K.
- TLP Group's largest Q1 2018 buy was Marsh: 7,143 shares worth $590K.
- TLP Group added most to iShares Biotechnology ETF in Q1 2018, an estimated $3.14M increase.
- TLP Group's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $19.3M.
- TLP Group fully exited Under Armour in Q1 2018, selling an estimated $487K.
- TLP Group's ten largest holdings make up 38% of its $146M portfolio in Q1 2018.
- TLP Group opened 108 new positions and closed 337 in Q1 2018.
- TLP Group's portfolio value rose 1.1% quarter-over-quarter to $146M.
Based on TLP Group's 13F filing for Q1 2018, filed 16 May 2018.